Cargando…

Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study

Our understanding of the protective immunity, particularly the long-term dynamics of neutralizing antibody (NAbs) response to SARS-CoV-2, is currently limited. We enrolled a cohort of 545 COVID-19 patients from Hubei, China, who were followed up up to 7 months, and determined the dynamics of NAbs to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xin, Nie, Sheng, Wang, Yanqun, Long, Quanxin, Zhu, Hong, Zhang, Xiaoyong, Sun, Jian, Zeng, Qinglang, Zhao, Jincun, Liu, Li, Li, Ling, Huang, Ailong, Hou, Jinlin, Hou, Fan Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129700/ https://www.ncbi.nlm.nih.gov/pubmed/34006847 http://dx.doi.org/10.1038/s41392-021-00611-6

Ejemplares similares

Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
por: Xu, Xin, et al.
Publicado: (2020)

Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
por: Wang, Yingdan, et al.
Publicado: (2022)

A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding
por: Wang, Yingdan, et al.
Publicado: (2022)

Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants
por: Liu, Yubin, et al.
Publicado: (2023)

Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance
por: Zou, Jia, et al.
Publicado: (2022)

The first Chinese national standards for SARS-CoV-2 neutralizing antibody
por: Guan, Lidong, et al.
Publicado: (2021)

Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses
por: Wang, Yingdan, et al.
Publicado: (2022)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants
por: Yan, Qihong, et al.
Publicado: (2022)

A Class of Shark‐Derived Single‐Domain Antibodies can Broadly Neutralize SARS‐Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape
por: Feng, Bo, et al.
Publicado: (2022)

The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients
por: Xu, Xin, et al.
Publicado: (2020)

The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients
por: Xu, Xin, et al.
Publicado: (2021)

Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury
por: Lin, Yong, et al.
Publicado: (2020)

A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strains
por: Yao, Hebang, et al.
Publicado: (2023)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
por: Gao, Xingsu, et al.
Publicado: (2022)

A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS/MS combined with immune repertoire
por: Yu, Meng, et al.
Publicado: (2022)

Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
por: Hu, Jie, et al.
Publicado: (2020)

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Ge, Jiwan, et al.
Publicado: (2021)

A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
por: Han, Xiaojian, et al.
Publicado: (2021)

Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
por: Chi, Xiangyang, et al.
Publicado: (2020)

Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice
por: Zhu, Airu, et al.
Publicado: (2021)

Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
por: Xue, Jun-biao, et al.
Publicado: (2021)

Corrigendum to “The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients” [Kidney Int. Rep. 2020 1416–1421]
por: Xu, Xin, et al.
Publicado: (2021)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
por: Tan, Yun, et al.
Publicado: (2020)

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
por: Guo, Huimin, et al.
Publicado: (2022)

Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
por: Vanshylla, Kanika, et al.
Publicado: (2022)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
por: Wang, Meiyu, et al.
Publicado: (2021)

Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster
por: Peng, Pai, et al.
Publicado: (2022)

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
por: Li, Tingting, et al.
Publicado: (2021)

Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization
por: Tang, Haijun, et al.
Publicado: (2022)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

Induction of significant neutralizing antibodies against SARS-CoV-2 by a highly attenuated pangolin coronavirus variant with a 104nt deletion at the 3'-UTR
por: Lu, Shanshan, et al.
Publicado: (2022)

The development of neutralizing antibodies against SARS-CoV-2 and their common features
por: Liu, Liu Daisy, et al.
Publicado: (2020)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
por: Xiaojie, Shi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lu9k32bkf5dr00o74qns7sgn9m